[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100349131":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":57,"centralContacts":61,"locations":67,"responsibleParty":83,"collaborators":65,"id":86,"slug":87,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":65,"eligibilityCriteria":92,"healthyVolunteers":93,"sex":94,"minAge":95,"maxAge":65,"enrollmentInfo":96,"targetDuration":65,"studyType":99,"phases":100,"briefSummary":103,"conditions":104,"keywords":65,"overallStatus":69,"whyStopped":65,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Henry Ford Health System","OTHER",[8,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Post-Operative Non Opioid Pain Protocol","EXPERIMENTAL","Patients will be administered a post-operative non-opioid pain protocol consisting of:\n\nCelecoxib Ketorolac Gabapentin Acetaminophen Diazepam",[13,14,15,16,17],"Drug: Celecoxib","Drug: Ketorolac","Drug: Gabapentin","Drug: Acetaminophen","Drug: Diazepam",{"label":19,"type":20,"description":21,"interventionNames":22},"Post-Operative Traditional Pain Protocol","ACTIVE_COMPARATOR","Patients will be administered a traditional post-operative pain protocol consisting of: Hydrocodone-acetaminophen 5-325",[23],"Drug: Hydrocodone-Acetaminophen",[25,31,37,42,47,52],{"type":26,"name":27,"description":9,"armGroupLabels":28,"otherNames":29},"DRUG","Celecoxib",[9],[30],"Celebrex",{"type":26,"name":32,"description":33,"armGroupLabels":34,"otherNames":35},"Hydrocodone-Acetaminophen","Traditionally used narcotic pain protocol",[19],[36],"Norco",{"type":26,"name":38,"description":9,"armGroupLabels":39,"otherNames":40},"Ketorolac",[9],[41],"Toradol",{"type":26,"name":43,"description":9,"armGroupLabels":44,"otherNames":45},"Gabapentin",[9],[46],"Neurontin",{"type":26,"name":48,"description":9,"armGroupLabels":49,"otherNames":50},"Acetaminophen",[9],[51],"Tylenol",{"type":26,"name":53,"description":9,"armGroupLabels":54,"otherNames":55},"Diazepam",[9],[56],"Valium",[58],{"name":59,"affiliation":5,"role":60},"Toufic R Jildeh, MD","PRINCIPAL_INVESTIGATOR",[62],{"name":59,"role":63,"phone":64,"phoneExt":65,"email":66},"CONTACT","517-230-8511",null,"tjildeh1@hfhs.org",[68],{"facility":5,"status":69,"city":70,"state":71,"zip":72,"country":73,"countryCode":74,"cosmosGeoPoint":75,"geoPoint":80,"contacts":81},"RECRUITING","Detroit","Michigan","48202","United States","US",{"type":76,"coordinates":77},"Point",[78,79],-83.04575,42.33143,{"lat":79,"lon":78},[82],{"name":59,"role":63,"phone":65,"phoneExt":65,"email":65},{"type":60,"investigatorFullName":84,"investigatorTitle":85,"investigatorAffiliation":5,"oldNameTitle":65,"oldOrganization":65},"Toufic R. Jildeh","Resident Investigator","100349131","phase-2-nonopioid-analgesia-after-labral-surgery-100349131",false,"NCT03825809","Nonopioid Analgesia After Labral Surgery","Traditional vs. Nonopioid Analgesia After Labral Surgery","Eligibility Criteria:\n\nInclusion Criteria:\n\n* All adult patients over age 18 and scheduled for a primary or revision labral surgery\n\nExclusion Criteria:\n\n* Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff",true,"ALL","18 Years",{"count":97,"type":98},100,"ESTIMATED","INTERVENTIONAL",[101,102],"PHASE2","PHASE3","This is a randomized, single blinded, standard of care controlled clinical trial. This project aims to compare postoperative pain control in patients in two treatment arms of rotator cuff repair: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen",[105],"Narcotic Use","2019-01-30",{"date":108,"type":109},"2019-01-31","ACTUAL",{"date":111,"type":109},"2019-01-22",{"date":113,"type":98},"2020-05-20",{"name":5,"class":6},1]